Ten thousand years ago, humans domesticated animals to reliably produce the proteins we needed — milk, eggs, meat. Precision fermentation domesticates a different organism to make the identical proteins: not a cow, a chicken, or a pig, but a genetically programmed microbe, grown in a steel tank. Same molecule. No animal.
Casein and whey are proteins. Egg white is proteins. The fat that makes cheese stretch and milk taste like milk is a specific, namable set of molecules — not "cow-ness," just chemistry a cow happens to be very good at manufacturing. Precision fermentation asks an unglamorous, extremely consequential question: if the product is a specific molecule, and a cow is just one biological factory for making it, why does the factory need to be a cow at all? A genetically programmed yeast or fungus, fed sugar in a fermentation tank, can produce the exact same protein — bit-for-bit identical at the molecular level, not an imitation — using a fraction of the land, water, and time a cow requires.
It is worth being precise about what this is not. Plant-based burgers, the last decade's headline alternative-protein story, are built from plant proteins arranged to resemble meat's taste and texture — an imitation, however good. Precision fermentation is different in kind: the whey protein a fermentation tank produces is not whey-like. It is whey, the same isoleucine sequence a cow's mammary gland produces, verified identical by mass spectrometry. This distinction matters commercially, because it means the product doesn't have to win a taste-and-texture argument against the real thing. It already is the real thing.
Letter 51 (The Biomimicry Economy) already flagged synthetic biology as a genuine platform technology — a $32 billion market in 2026, heading toward $239 billion by 2035, sitting underneath a bio-economy projected to reach $30 trillion by 2050. Precision fermentation is one of synthetic biology's most commercially advanced applications, because the target molecules (milk and egg proteins) are unusually well-characterised, the regulatory pathway for "identical to an existing food" is more tractable than for a genuinely novel food, and the fermentation infrastructure already exists at scale — it's the same tank technology the brewing and pharmaceutical industries have used for decades, repurposed.
"A cow is a solar-powered, self-repairing, self-replicating factory for turning grass into protein, refined over millions of years of evolution. It is also spectacularly inefficient at the one job we actually need from it. Precision fermentation keeps the protein and deletes the cow."
Perfect Day was first to bring precision-fermented whey protein to market and has since supplied it into ice cream, protein powders, and cream cheese sold on real shelves, not just in pilot batches. The Every Company (formerly Clara Foods) does the same for egg proteins, supplying food manufacturers rather than selling direct to consumers — the deliberately unglamorous, high-leverage position of being the ingredient inside someone else's product. Remilk and Formo are pursuing the same dairy-protein thesis from Israel and Germany respectively, both with regulatory approvals already secured in multiple jurisdictions. New Culture is targeting mozzarella specifically, betting that the single most commercially important cheese-melt behaviour is worth solving as its own product.
Precision fermentation is not yet cheaper than dairy at commodity scale, and pretending otherwise would be dishonest. Fermentation capacity is still being built out, and the cost curve depends on the same kind of manufacturing-scale learning curve that made solar and lithium-ion batteries cheap — real, but not instant, and not guaranteed to arrive on any particular schedule. What precision fermentation has already won is the high-value, ingredient-grade segment: specialty proteins for infant formula (where sourcing purity commands a premium regardless of price), sports nutrition, and allergen-free dairy alternatives for the meaningful population that is lactose intolerant or milk-protein allergic, not merely dairy-averse by preference.
Letter 32 (Water & Food) already established water as a load-bearing constraint on the entire global food system, not a peripheral environmental concern. Dairy and meat production are disproportionately water- and land-intensive relative to the protein they yield. A fermentation tank produces the same protein mass on a footprint measured in factory floor space, not pasture acreage, and on a timeline measured in days, not the months-to-years biological cycle of raising an animal. As emerging-market middle classes add hundreds of millions of new consumers with rising protein demand — the same demographic dividend driving the $1Q thesis broadly — the physical constraint is not manufacturing capacity. It is land and water that does not exist to be added. Precision fermentation is one of the few technologies that adds protein supply without requiring more of either.
"The question was never whether the world could afford real dairy protein forever. It was whether the world could afford the land and water a cow needs to make it. Precision fermentation is the first serious answer that doesn't require anyone to eat less protein."
Three things keep this from being a settled thesis. First, regulatory pace varies enormously by jurisdiction — the same product can be approved in Singapore and Israel while still working through a slower approval process elsewhere, which fragments any single company's addressable market unevenly. Second, consumer perception is not guaranteed to follow the science; "lab-grown" carries a stigma that "identical molecule, different factory" does not fully dissolve just because it's technically accurate. Third, and most concretely: capital intensity. Building fermentation capacity at a scale that meaningfully dents global dairy and egg protein demand requires the same kind of multi-billion-dollar infrastructure buildout as any other advanced manufacturing category, and several well-funded companies in this space have already had to scale back ambitions when capital markets tightened.
This is not a story about whether people will eat differently. It is a story about whether the same proteins people already eat can be manufactured without the land, water, and time an animal requires to make them. That is a narrower, more provable claim than "the future of food" — and narrower, provable claims are exactly the kind this letter series has learned to trust. Perfect Day, The Every Company, Remilk, Formo, and New Culture are not selling a vision. They are selling whey, egg white, and mozzarella that pass a mass spectrometer test. The economics are not there yet at commodity scale. The chemistry already is.
Founder, NextGen Economics · Bangalore, India · July 2026
Sources: Letter 51 (The Biomimicry Economy) · Letter 32 (Water & Food) · Letter 95 (Eating the World) · Public product and regulatory disclosures from Perfect Day, The Every Company, Remilk, Formo, and New Culture.
Not investment advice. All investments carry risk including loss of capital.